Mallinckrodt PLC (MNK)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

COLLEGE BUSINESS & TECHNOLOGY PARK DUBLIN 15, IRELAND D15

Mallinckrodt PLC develops, manufactures, markets, and distributes branded and generic specialty pharmaceuticals, active pharmaceutical ingredients (API), and diagnostic imaging agents worldwide.

Data as of 2020-08-01
Market Cap188.335 Million Shares Outstanding84.455 Million Avg 30-day Volume5.746 Million
P/E Ratio Dividend Yield EPS-14.32
Price/Sales0.085 Price cash flow ratio0.3 Price free cash flow ratio0.5
Book Value22.45 Price to Tangible Book-0.04 Alpha-0.05
Short Interest Ratio11.95 % Short Interest to Float49.4 R-squared0.301286
BETA5.39623 52-week High/Low6.87 / 1.0 Stddev0.42298

Are you looking for this stock instead?

View SEC Filings from MNK instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 207 44 (2.88%)
Aggregate 13F shares on 03/31/2020: 65.855 Million 29.428 Million
Aggregate 13F shares on 12/31/2019: 77.525 Million 43.125 Million
Percent change: -15.05% -31.76%
Funds creating new positions: 35 8
Funds Adding to an existing position: 50 10
Funds closing out their position: 37 16
Funds reducing their position: 49 16
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MNK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MNK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FLYNN JAMES E

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD MGMT L.P.

DEERFIELD PARTNERS, L.P.

  • Director
  • 10% Owner
  • DIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATION
3,360,000 2020-07-21 0

BAILEY DON M

  • Director
0 2020-07-01 0

RUSSELL ANGUS C.

  • Director
0 2020-07-01 1

LURKER NANCY PRESIDENT & CEO

784,467 2020-06-30 0

ROSA-BJORKESON DAGMAR

  • Director
0 2020-06-25 0

PAULSON & CO. INC.

14,326,996 2020-06-24 0

PAYA CARLOS V

  • Director
56,712 2020-06-23 1

CARROLL J MARTIN

  • Director
0 2020-06-18 1

YOUNGBLOOD DR KNEELAND

  • Director
1,927 2020-06-10 1

PHILLIPS GARY M.

  • Director
0 2020-06-09 0

REED JOANN A

  • Director
48,060 2020-06-08 1

REASONS BRYAN M.

  • Director
16,209 2020-06-04 1

TASSE DANIEL

0 2020-05-29 0

CARLUCCI DAVID R

  • Director
47,107 2020-05-13 1

NORTON DAVID Y

  • Director
26,167 2020-05-13 1

CARTER PAUL RUTHERFORD

  • Director
20,320 2020-05-13 1

WHITAKER ANNE CLEM

  • Director
21,087 2020-05-13 1

GULYAS DIANE H.

  • Director
13,140 2020-05-12 0

SCHAEFER KATHY A SR. VP FIN & CORP. CONTROLLER

  • Officer
23,791 2020-04-01 3

WATKINS IAN J EVP AND CHIEF HR OFFICER

  • Officer
52,863 2020-04-01 2

O'NEILL HUGH M. EVP & CHIEF COMM & OPS OFCR

  • Officer
79,706 2020-04-01 2

ROMANO STEVEN J. EXEC. VP & CHIEF SCI. OFCR

  • Officer
72,637 2020-04-01 2

CASEY MARK J EVP AND CHIEF LEGAL OFFICER

  • Officer
47,302 2020-04-01 2

HARBAUGH MATTHEW K EVP AND CFO

  • Officer
0 2020-03-02 0

HICKS MICHAEL-BRYANT SEE REMARKS

  • Officer
42,137 2020-03-01 0

TRUDEAU MARK PRESIDENT AND CEO

  • Officer
  • Director
228,384 2020-01-03 1

HATTEN SANDRA L SEE REMARKS

  • Officer
59,165 2019-12-12 0

ZACCAGNINO JOSEPH A

  • Director
36,481 2019-05-15 0

SCHOLZ FRANK EVP & CHF OPS & DIG INNOV OFF

  • Officer
89,614 2019-04-01 0

SHEEHY KAREN PATRUNO CHIEF COMPLIANCE OFFICER

  • Officer
13,936 2019-04-01 0

KEGLER GEORGE A. EVP & CFO, INTERIM

  • Officer
14,985 2019-01-09 0

EDWARDS PETER G EVP & GC

  • Officer
0 2018-12-31 0

LLOYD RONALD K. EXEC. VP & PRES, HOSPITAL

  • Officer
38,957 2018-04-02 0

BOOTH MELVIN D

  • Director
38,202 2018-03-01 0

FISCHER MEREDITH B CHIEF PUBLIC AFFAIRS OFFICER

  • Officer
28,318 2018-01-03 0

LANNUM COLEMAN N III SR. VP INVESTOR STRATEGY & IRO

  • Officer
35,510 2018-01-03 0

THOMPSON VIRGIL D

  • Director
No longer subject to file 2017-03-01 0

FUREY RAYMOND J. CHIEF COMPLIANCE OFFICER

  • Officer
6,462 2017-01-04 0

CARLSON TERRANCE L INTERIM GENERAL COUNSEL

  • Officer
2,549 2015-12-11 0

SALTARELLI MARIO D. SR. VP & CHIEF SCIENCE OFCR.

  • Officer
6,808 2015-05-18 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments